Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomarker World Congress 2005.

Pollen K F Yeung1

  • 1Dalhousie University, Pharmacokinetics and Metabolism Laboratory, School of Pharmacy, Burbridge Building, Halifax, NS, Canada. pollen.yeung@dal.ca

Idrugs : the Investigational Drugs Journal
|July 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pilot Study to Assess Adenosine 5'-triphosphate Metabolism in Red Blood Cells as a Drug Target for Potential Cardiovascular Protection.

Cardiovascular & hematological disorders drug targets·2015
Same author

Diltiazem reduces mortality and breakdown of ATP in red blood cell induced by isoproterenol in a freely moving rat model in vivo.

Metabolites·2014
Same author

Effect of acute exercise on cardiovascular hemodynamic and red blood cell concentrations of purine nucleotides in hypertensive compared with normotensives rats.

Therapeutic advances in cardiovascular disease·2013
Same author

Comparing pharmacokinetics and metabolism of diltiazem in normotensive Sprague Dawley and Wistar Kyoto rats vs. spontaneously hypertensive rats in vivo.

Drug metabolism and drug interactions·2011
Same author

Exercise improves hemodynamic profiles and increases red blood cell concentrations of purine nucleotides in a rodent model.

Therapeutic advances in cardiovascular disease·2010
Same author

Pharmacokinetics and metabolism of diltiazem following multiple doses: comparing normotensive rat vs. hypertensive rat models in vivo.

Drug metabolism letters·2009

This conference highlighted emerging biomarker science for targeted drug discovery and personalized medicine. It also fostered networking for medical diagnostics and biopharmaceutical development professionals.

Area of Science:

  • Biomarker Science
  • Drug Discovery and Development
  • Personalized Medicine

Background:

  • Emerging issues in biomarker development were discussed.
  • The role of biomarker science in advancing targeted therapies was explored.
  • The scientific basis for personalized medicine was a key focus.

Framework:

  • Biomarker discovery and validation pathways.
  • Integration of biomarker data into clinical development.
  • Regulatory considerations for diagnostic and biopharmaceutical products.

Implementation:

  • Selected talks and posters from the conference were summarized.
  • Networking opportunities for professionals in medical diagnostics and biopharmaceuticals were facilitated.
  • Discussions covered the translation of biomarker research into clinical applications.

Related Experiment Videos

Implications:

  • Advancing targeted drug discovery through robust biomarker strategies.
  • Establishing a scientific foundation for personalized medicine.
  • Facilitating collaboration and business development in the medical technology sector.